Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Mark Gregory

Concepts (182)

Concepts are derived automatically from a person's publications.

The timeline below shows the dates (blue tick marks) of publications associated with Mark Gregory's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Mark Gregory has written about over time.
Proto-Oncogene Proteins c-myc, 7 publications between 2000 and 2012, average publication date January 2004. Fusion Proteins, bcr-abl, 3 publications between 2010 and 2014, average publication date April 2013. Leukemia, Myelogenous, Chronic, BCR-ABL Positive, 3 publications between 2010 and 2014, average publication date April 2013. Drug Resistance, Neoplasm, 4 publications between 2012 and 2022, average publication date May 2016. Ataxia Telangiectasia Mutated Proteins, 1 publications between 2016 and 2016, average publication date October 2016. Gene Expression Regulation, Leukemic, 1 publications between 2016 and 2016, average publication date October 2016. Glucosephosphate Dehydrogenase, 1 publications between 2016 and 2016, average publication date October 2016. Xenograft Model Antitumor Assays, 4 publications between 2013 and 2019, average publication date October 2016. Benzothiazoles, 2 publications between 2016 and 2017, average publication date March 2017. Phenylurea Compounds, 2 publications between 2016 and 2017, average publication date March 2017. Benzeneacetamides, 1 publications between 2017 and 2017, average publication date September 2017. Glutaminase, 1 publications between 2017 and 2017, average publication date September 2017. Thiadiazoles, 1 publications between 2017 and 2017, average publication date September 2017. Oxidation-Reduction, 2 publications between 2016 and 2019, average publication date January 2018. fms-Like Tyrosine Kinase 3, 4 publications between 2014 and 2022, average publication date January 2018. Antineoplastic Agents, 4 publications between 2012 and 2023, average publication date February 2018. Glutamine, 2 publications between 2017 and 2019, average publication date June 2018. Leukemia, Myeloid, Acute, 3 publications between 2016 and 2022, average publication date February 2019. Energy Metabolism, 1 publications between 2019 and 2019, average publication date March 2019. Leukemia, 1 publications between 2019 and 2019, average publication date March 2019.

To see the data from this visualization as text, click here.
Gregory's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)